List of insiders holdings for ARQULE INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner | 2020-02-14 17:00:52 | 4,902,383 0 | 4,902,383 | Form 13G |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC LAMPERT MARK N 10% Owner | 2020-02-14 17:00:52 | 4,902,383 0 | 4,902,383 | Form 13G |
| PFIZER INC 10% Owner | 2016-03-17 16:43:31 | 3,273,679 0 | 3,273,679 | Form 13D |
| CHARPIE RICHARD A 10% Owner | 2004-09-28 16:55:26 | 1,393,532 0 | 1,393,532 | Form 13G |
| HILL STEPHEN A President and CEO | 2007-10-09 20:45:31 | 1,115,000 0 | 1,115,000 | Form 4 |
| CHAN THOMAS C K Chief Scientific Officer | 2012-02-03 15:28:44 | 561,000 0 | 561,000 | Form 4 |
| LI CHIANG J EVP, Chief Scientific Officer | 2007-01-30 17:01:16 | 293,125 0 | 293,125 | Form 4 |
| RULEWSKI NIGEL J Former Chief Medical Officer | 2008-07-24 16:47:33 | 162,500 0 | 162,500 | Form 4 |
| JACOBS J DAVID VP and General Counsel | 2005-01-20 17:21:28 | 158,500 0 | 158,500 | Form 4 |
| MAWHINNEY LOUISE VP and Chief Financial Officer | 2006-01-23 15:40:33 | 155,000 0 | 155,000 | Form 4 |
| Weiskopf Robert J Chief Financial Officer | 2019-03-14 16:40:39 | 80,000 0 | 80,000 | Form 4 |
| Simonian Nancy A Director | 2010-05-17 15:36:29 | 65,000 0 | 65,000 | Form 4 |
| HA NGOC TUAN Director | 2006-05-22 10:56:21 | 43,000 0 | 43,000 | Form 4 |
| CAUTREELS WERNER Director | 2005-05-19 11:53:26 | 33,000 0 | 33,000 | Form 4 |
| AVAKIAN LAURA Director | 2005-05-19 10:56:05 | 33,000 0 | 33,000 | Form 4 |
| ELIA ARIEL Director | 2004-05-19 13:00:13 | 30,000 0 | 30,000 | Form 4 |
| ASTRUE MICHAEL J Director | 2006-05-22 10:14:35 | 25,000 0 | 25,000 | Form 4 |
| Woodrich Richard H Acting Chief Financial Officer | 2006-09-26 16:36:52 | 300 0 | 300 | Form 3/A |
| Messenger William G Director | 2020-01-16 15:58:25 | 0 0 | 0 | Form 4 |
| BARABE TIMOTHY C Director | 2020-01-16 15:58:11 | 0 0 | 0 | Form 4 |
| Kelley Susan L. Director | 2020-01-16 15:57:57 | 0 0 | 0 | Form 4 |
| Nussbaum Ran Director | 2020-01-16 15:57:43 | 0 0 | 0 | Form 4 |
| LINDSAY RONALD M Director | 2020-01-16 15:57:26 | 0 0 | 0 | Form 4 |
| ZENNER PATRICK J Director | 2020-01-16 15:56:38 | 0 0 | 0 | Form 4 |
| Pucci Paolo Chief Executive Officer | 2020-01-16 15:56:24 | 0 0 | 0 | Form 4 |
| Lawrence Peter S President and COO | 2020-01-16 15:56:00 | 0 0 | 0 | Form 4 |
| SCHEGERIN MARC CFO and Treasurer | 2020-01-16 15:55:43 | 0 0 | 0 | Form 4 |
| LOBERG MICHAEL D Director | 2020-01-16 15:55:31 | 0 0 | 0 | Form 4 |
| SCHWARTZ BRIAN See Remarks | 2020-01-16 15:55:08 | 0 0 | 0 | Form 4 |
| SCHAMBER BLAINE VP Finance, CAO | 2020-01-16 15:54:41 | 0 0 | 0 | Form 4 |
| Merck & Co. Inc. Merck Sharp & Dohme Corp. 10% Owner | 2019-12-16 17:12:46 | 0 0 | 0 | Form 3 |